Gene · 432
Papers2,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A hepatic-targeted glycogen-based nano-platform enables efficient CTGF silencing and attenuates liver fibrosis. | Nanotechnology | 2026 | 41662774 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| The ER membrane protein complex acts as a chaperone to promote the biogenesis of multi-bundle membrane proteins. | bioRxiv | 2026 | 41648177 | PubTator, text mining | PubMed |
| Quantum optimized hierarchical chunk encoding with robust embedding for perceptual integrity and compression tolerant visual data protection. | Sci Rep | 2026 | 41634231 | PubTator, text mining | PubMed |
| RNA-Based Therapies for Inherited Metabolic Disorders. | J Inherit Metab Dis | 2026 | 41621836 | PubTator, text mining | PubMed |
| Advances in isolation and detection technologies and immunotherapy applications of circulating tumor cells (Review). | Oncol Rep | 2026 | 41614401 | PubTator, text mining | PubMed |
| Preclinical evaluation of gefitinib and betulin-loaded surface functionalized liposomes for the treatment of hepatocellular carcinoma via asialoglycoprotein receptor targeting. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41611852 | PubTator, text mining | PubMed |
| B Vitamin Deficiencies and Associated Neuropathies. | Curr Nutr Rep | 2026 | 41609902 | PubTator, text mining | PubMed |
| Isolation and typing techniques for circulating tumor cells. | Biomark Res | 2026 | 41606691 | PubTator, text mining | PubMed |
| Gene Editing Therapies Targeting Lipid Metabolism for Cardiovascular Disease: Tools, Delivery Strategies, and Clinical Progress. | Cells | 2026 | 41597209 | PubTator, text mining | PubMed |
| Serum soluble ASGR1 concentration is elevated in patients with metabolic dysfunction-associated steatotic liver disease and is associated with adiponectin. | BMJ Open Diabetes Res Care | 2026 | 41592894 | PubTator, text mining | PubMed |
| Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies. | J Nanobiotechnology | 2026 | 41578333 | PubTator, text mining | PubMed |
| Discovery of Goethe's amber ant: its phylogenetic and evolutionary implications. | Sci Rep | 2026 | 41571851 | PubTator, text mining | PubMed |
| Engineered Akkermansia muciniphila vesicles for targeted pyroptosis and trained immunity to enhance immunotherapy in hepatocellular carcinoma. | Cell Rep Med | 2026 | 41564859 | PubTator, text mining | PubMed |
| A Position Paper on Lipoprotein(a) From the Lipoprotein(a) Task Force of the Korean Society of Lipid and Atherosclerosis: Current Evidence, Clinical Applications, and Future Directions. | Korean Circ J | 2026 | 41560299 | PubTator, text mining | PubMed |
| Electron-Donating Ligand in Oxidorhenium(V) Chemistry: Consequences for Isomerism and Catalyst Properties. | Inorg Chem | 2026 | 41556367 | PubTator, text mining | PubMed |
| Role of tannin-rich plant fractions in hepatoprotection: a nanotechnology perspective. | Discov Nano | 2026 | 41548157 | PubTator, text mining | PubMed |
| Circulating hepatocyte-derived extracellular particles as potential biomarker of steatohepatitis progression to fibrogenesis: Exploring the impact of smoking. | Dig Liver Dis | 2026 | 41521111 | PubTator, text mining | PubMed |
| Increased Asialoglycoprotein Receptor 1 Level in Granulosa Cell as a Potential Biomarker for Polycystic Ovary Syndrome. | Reprod Sci | 2026 | 41491768 | PubTator, text mining | PubMed |
| Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy. | J Gastroenterol Hepatol | 2026 | 41489120 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/432/papers?page=5